Get started
RocketTickers

RedHill Biopharma Receives FDA Approval for COVID-19 Clinical St

Long
Redhill Biopharma Ltd. (NASDAQ:RDHL)  
RocketTickers  
NASDAQ:RDHL   Redhill Biopharma Ltd.
Beyond Technical Analysis
3
0
beyondta
RDHL: RedHill Biopharma Ltd.
2020-05-08 07:00:10
RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.